|
FY2025
12 months to Dec 31, 2025
|
FY2024
11 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Income earned on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Due to a related party | ||
| Accounts payable and accrued expenses | ||
| Net Cash Used in Operating Activities | ||
| Purchase of marketable securities held in Trust Account | ||
| Net Cash Used in Investing Activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of ordinary shares to Sponsor | ||
| Proceeds from issuance of promissory note to related party | ||
| Repayment of promissory note to related party | ||
| Proceeds from sale of public units through public offerings, net of underwriters’ discount | ||
| Proceeds from ordinary shares issued in private placement | ||
| Payment of offering costs | ||
| Net Cash Provided by Financing Activities | ||
| Net Change in Cash | ||
| Cash, Beginning of Period | ||
| Cash, End of Period | ||
| Supplemental Disclosure of Non-cash Investing and Financing Activities: | ||
| Offering costs included in accrued offering costs | ||
| Representative shares issued and charged to offering costs | ||
| Accretion of ordinary shares subject to redemption value |
Loading...
